The National Heart, Lung, and Blood Institute (NHLBI) last week sent a call for applications for ancillary studies in conjunction with on-going clinical trials. According to the announcement, ancillary studies in clinical trials of cardiovascular, respiratory, hematological and sleep disorders will be considered if closely coupled to NHLBI mission area and justified by the time-sensitive nature of the proposal.

Read the full announcement, including information on the special electronic application and review and funding procedures, online at